logo
You don't need to accomplish things to matter

You don't need to accomplish things to matter

Fast Companya day ago

Not long ago, a client of mine—let's call her Maya—shared something that struck me.
'I had a rare Sunday with nothing urgent on my plate. My kids were with their grandparents. My inbox was quiet. I could have done anything. Instead of feeling relaxed, I panicked. I literally didn't know what to do with myself.'
She laughed softly but tears were in her eyes. 'I realized . . . I don't know how to exist without a task list. If I'm not accomplishing something, I feel like I don't matter.'
Maya isn't alone. In my coaching work, I've heard this story many times— women who have full, meaningful lives yet feel they're only as good as what they checked off today.
In a culture that rewards output and treats busyness like a badge of honor, it's easy to confuse productivity with worth. But what happens when you slow down —or are forced to? Who are you without the to-do list, the perfect calendar, and the high performance?
This article invites you to pause and honestly examine where your worth may be tied to how much you get done. It's about recognizing patterns that keep you in constant motion—and beginning to loosen their grip so your value is rooted in something more lasting.
Warning signs you might be outsourcing your self-worth to productivity
You don't have to be burned out or in crisis to be stuck in this trap. Often, it's invisible—especially when things seem to be going well.
Here are some subtle signs:
You feel anxious or restless when you're not actively 'getting something done.'
You judge your day's success by accomplishments, not feelings.
You feel guilty or uncomfortable during downtime.
You struggle to enjoy activities unless they're 'productive' (reading must educate, exercise must burn calories).
You only feel good about yourself when exceeding expectations—at work or home.
Another client, Elena—a physician and mom of three—said, 'I know rationally that I'm a good mom and doctor. But the only time I feel that way is when I'm accomplishing something measurable—publishing, presenting, finishing charts. Otherwise, I feel like I'm failing.'
Elena wasn't asking to do less. She wanted to feel enough even when she wasn't at full throttle.
That distinction matters. Reclaiming your self-worth doesn't mean abandoning ambition. It means building a foundation where your identity isn't tied to output highs and lows.
Why this runs so deep
Tying worth to productivity isn't a personal flaw—it's shaped by powerful cultural forces. We live in a society that prizes output, where worth is measured by results, not relationships or inner experience. Women are socialized to be competent, accommodating, and endlessly available—to anticipate needs, keep things running, and never drop the ball.
Add motherhood, with its endless work and little feedback, and it's easy to internalize that your value depends on how much you handle without breaking.
The pandemic intensified this. With work, school, and home merging, many working moms became the nerve center—managing logistics, meals, meetings, and everyone's emotions. The doing never stopped. And when people praised our resilience and ability to 'keep it together,' we absorbed the message that being useful was what made us worthy.
The costs of outsourcing your worth
This isn't sustainable. Even if it works temporarily, it erodes well-being. Your sense of self rises and falls with accomplishment. Burnout looms as rest feels like failure. Disconnection creeps in—you struggle to be present with loved ones unless everything is tied up.
When things go off script, disappointment turns to shame, as if falling short means you're fundamentally flawed.
Most damagingly, this mindset convinces you rest, joy, and self-compassion are rewards to be earned, not essential parts of being human. When worth is always up for reevaluation, peace remains out of reach.
What reclaiming your worth looks like
This work is slow and layered—not a quick fix or a slogan. It's a recalibration of how you relate to yourself.
Start here:
1. Notice the Narratives
Pay attention to thoughts that arise when you're not productive: ' I should be doing more,' ' I'm falling behind,' ' I don't deserve to rest yet. ' Notice whose voice this echoes—a parent, boss, or cultural script? Naming these is the first step to disarming them.
2. Redefine Success
Create space for a fuller definition of success: being present for bedtime without planning tomorrow, holding a boundary at work, or letting something be 'good enough.' Reflect daily: What felt aligned? When did I feel like myself? Where did I honor my values?
3. Practice Being, Not Just Doing
Choose small moments to simply be: sit with coffee without scrolling, walk without exercising, and rest without 'earning' it. Your nervous system may resist at first—that's normal. Over time, you'll build capacity to sit with yourself without judgment.
4. Anchor to Identity, Not Output Ask: Who am I when I'm not performing or producing? This can feel scary but also freeing. You are more than a multitasking manager—you are a person with humor, intuition, creativity, and resilience. Begin rooting your worth in being human, not heroic.
One client, a lawyer and mom of two, shared: 'I still work hard, but now I can pause during the day to breathe. I let dishes wait without calling myself lazy. And strangely, I feel more powerful—not less—because my worth isn't riding on every task.'
Being enough
High-achieving moms are admired for how much they handle—but that admiration can come at a cost. Beneath competence and reliability often lies a quiet desire: to feel whole even when nothing is getting done.
You don't need to give up your drive or goals. But you deserve a life where worth isn't constantly measured: a life where rest is allowed, not earned; where joy has space without justification; where being enough isn't something you prove—it's something you simply trust.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Michigan officials report lowest infant mortality rates in state history
Michigan officials report lowest infant mortality rates in state history

CBS News

time11 minutes ago

  • CBS News

Michigan officials report lowest infant mortality rates in state history

Michigan is recording its lowest infant mortality in history, with a combination of mother-and-baby health initiatives credited for pushing up survival rates. The topic was among those discussed during the annual Maternal Infant Health Summit, which met June 17 and 18 in Lansing. The event, hosted by the Michigan Department of Health and Human Services, included sharing ideas on how to improve the health of Michigan's new mothers and babies. "We are proud of the improvements we are making and will continue to make when it comes to the health of moms and babies," said Elizabeth Hertel, MDHHS director, in a press release about the conference. Infant mortality is defined as the death of a baby who was born alive but died before their first birthday. The most common causes include prematurity, low birth weight, congenital anomalies and accidents. The data provided by state officials is as follows: During 2023, 607 Michigan infants under the age of 1 died. That's a ratio of 6.1 infant deaths per 1,000 live births. During 2022, there were 650 deaths for a ratio of 6.3 deaths per 1,000 live births. The Healthy Moms, Healthy Babies initiative, launched in 2021, is getting credit for this improvement. The specific pieces in that initiative include continuing Medicaid coverage to one year after birth, making doula services available to expecting parents and the CenteringPregnancy model of care. Doulas are trained to provide guidance, educational and emotional support during prenatal, labor and delivery and postpartum times. There are more than 700 doulas on Michigan's Doula Registry; nearly 500 of whom are Medicaid-enrolled providers. CenteringPregnancy is an approach that integrates routine prenatal care with additional education about health, pregnancy and parenting within a group setting. In Michigan, there are currently 35 CenteringPregnancy sites and three CenteringParenting sites, including some medical providers and clinic locations in Ann Arbor, Detroit, Livonia, Pontiac, Sterling Heights, Westland and Ypsilanti.

Newest Covid variant causing ‘razor blade throat.' What to know
Newest Covid variant causing ‘razor blade throat.' What to know

Yahoo

time20 minutes ago

  • Yahoo

Newest Covid variant causing ‘razor blade throat.' What to know

A new Covid variant spreading around the U.S. may come with an incredibly unfortunate symptom now commonly referred to as 'razor blade throat.' NB.1.8.1, which is also known as or 'Nimbus,' is now nearly the most prevalent omicron lineage tracked by the Centers for Disease Control and Prevention. As the name implies, infection may lead to an incredibly painful sore throat, according to experts. Other symptoms, though, are more typical of a Covid infection, including fever, chills, cough, shortness of breath, and the loss of taste or smell. 'A 'razor blade throat' is a very descriptive term describing severe sore throat pain — as if their throat is covered with razor blades — (like) with various viral infections,' Dr. Aaron Glatt, chair of the department of medicine and chief of infectious diseases at Mount Sinai South Nassau in New York, told 'While not specific to Covid-19, this expression has been used to describe sore throat symptoms in some patients with the most recent Covid-19 variant,' he said. But although the new omicron variant may result in a painful infection, experts say that it does not appear to be more severe than others. 'Every time you get a new strain, it always is a little bit more transmissible than what came before it,' Dr. Peter Chin-Hong, a UCSF infectious disease specialist, told SFGATE. 'Just like a pop song is more catchy when it rises to the top of the charts. And this particular one, Nimbus, is not just proportionally higher right now in California, the speed at which it's rising in the charts is also high … but it's not more severe.' Just how virulent it is remains a topic of discussion. 'What sets NB.1.8.1 apart is how quickly it spreads,' explains Dr. Magdalena Sobieszczyk, chief of the Division of Infectious Diseases at NewYork-Presbyterian/Columbia University Irving Medical Center, said in a statement. 'It has a genetic advantage: mutations that make it easy for it to bind to receptors on human cells. The mutations could allow NB.1.8.1 to spread faster and, therefore, infect more people.' The World Health Organization has designated Nimbus as a 'variant under monitoring,' and considers the public health risk low globally. Current vaccines are expected to remain effective. But the longevity of the availability of Covid vaccines in the U.S. remains murky. Health and Human Services Secretary Robert F. Kennedy, Jr., said last month that shots are no longer recommended for healthy children and pregnant women. He has also removed members of the Centers for Disease Control and Prevention's vaccine advisory panel and replaced them with people who have been skeptical of Covid vaccines and mandates.

FDA Approves Dupilumab for Bullous Pemphigoid
FDA Approves Dupilumab for Bullous Pemphigoid

Medscape

time20 minutes ago

  • Medscape

FDA Approves Dupilumab for Bullous Pemphigoid

Dupilumab has been approved by the FDA for the treatment bullous pemphigoid in adults, the manufacturer Regeneron announced. Dupilumab (Dupixent), a human monoclonal antibody that inhibits interleukin (IL)-4 and IL-13 signaling, is now approved in the United States for eight diseases, including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. Dupilumab, administered by subcutaneous injection, is the first targeted treatment to be approved in the United States for bullous pemphigoid, according to the company's press release. The approval follows a supplemental New Drug Application filed with the FDA in February 2025 and is based on data from ADEPT, a pivotal phase 2/3 study in more than 100 adults with moderate-to-severe bullous pemphigoid known as, according to Regeneron. The study's design was published in Advances in Therapy. In the study, 106 patients were randomized to 300 mg of subcutaneous dupilumab or a placebo injection every 2 weeks, added to standard-of-care oral corticosteroids. At 36 weeks, 18.3% of patients in the dupilumab group achieved the primary endpoint of sustained disease remission compared with 6.1% of those in the placebo group. The study defined sustained remission as a combination of complete clinical remission and no relapse after an oral corticosteroid taper by 16 weeks, with no use of rescue therapy during the study period. More patients treated with dupilumab achieved a clinically meaningful reduction in itching (38.3% vs 10.5%), and the median cumulative oral corticosteroid dose in the dupilumab-treated group was 2.8 g vs 4.1 g in the placebo group, according to the company release. The most common adverse events among patients receiving dupilumab (affecting 2% or more) compared with those receiving placebo were arthralgia, conjunctivitis, blurred vision, herpes viral infections, and keratitis. One patient receiving dupilumab also developed acute generalized exanthematous pustulosis; no cases were reported among those receiving placebo. The dupilumab study was funded by Sanofi and Regeneron, the companies co-developing dupilumab.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store